Oct 12, 2016 by Brian FeroldiWhich Healthcare Company Is the Best Dividend Stock?By running through a simple checklist, we can narrow the list of the 10 highest-yielding healthcare stocks down until we have a single recommendation for your portfolio.
Oct 11, 2016 by Brian FeroldiWhy Illumina, Inc. Is Plunging TodayShares drop in response to preliminary third-quarter results that came in well short of management's guidance.
Oct 10, 2016 by Brian FeroldiWhy Clovis Oncology Inc. Rose 52.7% in SeptemberTraders bid up shares in response to news that the FDA will not hold an advisory committee meeting to discuss the company's recent drug submission.
Oct 10, 2016 by Brian FeroldiWhy Merrimack Pharmaceuticals Inc. Rose 38% in SeptemberShares shot up after script data showed that demand for Onivyde continues to grow.
Oct 10, 2016 by Brian FeroldiHere's Why Intrexon Gained 14.2% in SeptemberShares rallied in response to the company showering its investors with a stream of good news.
Oct 9, 2016 by Brian FeroldiWhat's Behind Keryx Biopharmaceuticals' 28.6% Jump in September?Shares bounced back after being obliterated in August, but big questions still remain unanswered.
Oct 8, 2016 by Brian Feroldi3 Proven Ways to Boost Your Retirement IncomeA little knowledge, the right investments, and some well-spent hours can keep your finances from floundering.
Oct 8, 2016 by Brian FeroldiHere's Why Ophtotech Corporation Dropped 16.5% in SeptemberShares drop over new concerns regarding the company's lead compound.
Oct 7, 2016 by Brian FeroldiWhy Idera Pharmaceuticals Inc Stock Is Falling AgainShares drop after the company announces pricing for its common stock offering.
Oct 6, 2016 by Brian FeroldiWhy Idera Pharmaceuticals Inc. Is Down Big TodayShares plunge in response to the announcement of a secondary share offering.
Oct 6, 2016 by Brian FeroldiWarren Buffett's 2 Worst Stocks of 2016 So FarThe oracle of Omaha has banked on both for a long time, but they've been pummeled this year. Now the question is, should you shun them, or buy for their potential rebounds?
Oct 6, 2016 by Brian Feroldi, Sean Williams, Brian Stoffel, Jason Hall, and Todd Campbell5 Retirement Stocks to Buy in OctoberLooking for a few stocks that offer income and growth potential? Here's a list of five companies that our team of contributors think fit the bill.
Oct 5, 2016 by Brian FeroldiIn Your 40s? 3 Stocks You Should Consider BuyingInvestors with decades of time ahead of them should consider taking a closer look at these three high-growth stocks.
Oct 5, 2016 by Brian FeroldiHere's Why BioTelemetry, Inc. Is Soaring TodayShares jump on the news that a major insurance company has decided to offer coverage on mobile cardiac telemetry devices.
Oct 5, 2016 by Brian FeroldiIf You're in Your 60s, Consider Buying These 3 StocksOlder investors may want to cut risk out of their portfolios, but they can't afford to get too conservative; these stocks offer a solid combination of income, growth potential and stability.
Oct 4, 2016 by Brian Feroldi, Daniel Miller, and Matt DiLallo3 Growth Stocks to Buy in OctoberLooking for a few stocks that can power your portfolio higher this month? Here are three growth companies that our team of contributors thinks deserve a closer look.
Oct 4, 2016 by Brian FeroldiWhy Progenics Pharmaceuticals, Inc. Is Rising TodayShares jump in response to positive comments from Wall Street.
Oct 2, 2016 by Brian Feroldi, Sean Williams, and Todd Campbell3 Top Biotech Stocks to Buy in OctoberOur healthcare contributors think these pharma companies deserve a closer look from investors.
Sep 30, 2016 by Brian FeroldiHere's Why Ophthotech Corporation Is Dropping TodayShares fall in response to bad news from a competing drug's clinical trial.
Sep 30, 2016 by Brian Feroldi3 Hot Stocks to Buy in OctoberEach one has already posted big gains year-to-date, but I don't think their rallies are over yet.
